Register for London
Speakers: Dr John Conibear, Dr Melissa Phillips, Miss Maria Lapuente, Dr Mukesh Mukesh
Venue: The King's Fund, The Maynard Theatre - 11-13 Cavendish Square, London, W1G 0AN
Join leading healthcare professionals for expert discussions on management of breast cancer patients. Experience dynamic sessions live from The King’s Fund London, streamed to regional locations across the country. Come and connect with local and national experts.
View Agenda
TIME |
SESSION |
SPEAKER(S) |
|
|
|
19:00-19:10 
|
|
Where are we now in the management of HER2+ metastatic breast cancer? |
|
|
19:10-19:40
|
|
Optimising second line treatment for HER2+ metastatic breast cancer |
|
Dr Melissa Phillips, Maria Lapuente |
|
19:40-20:10
|
|
MDT discussion: Practical management of patients on Enhertu |
|
Chaired by Dr John Conibear;
Presented by:
Maria Lapuente;
Dr Melissa Phillips;
Dr Mukesh Mukesh |
|
20:10-20:30
|
|
|
|
|
|
|
|
|
NB: Please note the agenda can be subject to change
|
|
REGISTER HERE
WORK ADDRESS
CONTACT INFORMATION
By opting in to Daiichi Sankyo and AstraZeneca's mailing list you will receive both promotional and/or non-promotional emails from both companies, including invitations to webinars and meetings.
Please note that each company must verify your contact details against its own Healthcare Professional contact information database and if your contact details are already available within the AstraZeneca database a representative from AstraZeneca will email you to confirm your opt-in status. Alternately, if your details are already available within Daiichi Sankyo database a representative from Daiichi Sankyo will send you an email.
In the scenario of your contact details not being available within either company's respective database, a Daiichi Sankyo and/or AstraZeneca representative will contact you to advise how you can be added to the database and confirm your opt-in status.
If you have elected to receive information about any of Daiichi Sankyo or AstraZeneca's productions or services and wish to opt-out of receiving such information you can do so by sending an email to the respective company. For AstraZeneca email privacyrequests@astrazeneca.com and for Daiichi Sankyo email data-protection@daiichi-sankyo.eu. There is also an unsubscribe link at the bottom of our mailings that can be clicked if you wish to opt-out.
Please note that registration does not automatically guarantee a place at this meeting. An email confirmation will be sent upon successful registration.
Your email address and personal information will be used to communicate electronically with you about this meeting. If you do not wish to receive any communication, then please email us at her2registration@HCPMED.NET.
Thank you for registering to attend the HER2 Horizons: Connecting the dots in breast cancer care meeting on Thursday, 3rd July 2025. An email confirming your registration will be sent to the email address you provided.
UK/ADC/04/25/0011 | May 2025